Advertisement
As section editor for the Pediatric, Adolescent, & Maternal Therapeutics(http://www.clinicaltherapeutics.com/ped.html) section (formerly thePediatric Research section), Dr. Spigarelli brings a wealth of knowledge anda strong background in addressing the issues surrounding these specialpopulations. He completed his residency in internal medicine and pediatricsat the University of Michigan Medical Center in Ann Arbor and his fellowshipin adolescent medicine at Cincinnati Children's Hospital Medical Center,where he currently remains on staff.
Advertisement
Pregnant women and children remain among the most vulnerable patientsundergoing therapy today due to a lack of critical information on the safety,tolerability, and efficacy of pharmacotherapies indicated for them. As Dr.Spigarelli states in his inaugural editorial, "To date, most medications usedin the treatment of illness in children have never been tested in them....This lack of crucial information has important implications for a variety ofstakeholders."
By refocusing the Pediatric, Adolescent, & Maternal Therapeutics(http://www.clinicaltherapeutics.com/ped.html) section, ClinicalTherapeutics(http://www.clinicaltherapeutics.com/) seeks to become thepremier venue for publication of clinical research in these specialpopulations and serve as an international forum for the timely discussion ofsafe and effective drug therapies in neonates, infants, children,adolescents, and pregnant or lactating women.
"As Editor of this section, I encourage each of you to review your filesfor data already obtained but not yet published, for data from ongoingstudies, and consider submitting those manuscripts to Clinical Therapeutics.Each additional piece of available data adds to the knowledge base needed toprovide the best health care for pregnant women and children."
An example of important pediatric information published by the journal isthe supplemental issue on Conquering Pain: The Hidden Cost of Immunizationsponsored by the Canadian Institutes of Health Research and the SickKidsFoundation. Also highlighting the journal's commitment to fosteringpublication of scientific research related to these special populations isthe upcoming focus issue on vaccines.
Articles can be submitted online or directly to [email protected];click here for Information for Authors(http://www.clinicaltherapeutics.com/ifa3.html).
For more information about this press release and Clinical Therapeutics,contact Julie E. Artim at:Phone: +44(0)908-547-2094 Email: [email protected] Website: ElsRapidPubs.com
SOURCE Clinical Therapeutics
